These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6127353)

  • 81. Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches.
    May PR; Lee MA; Bacon RC
    Clin Neuropharmacol; 1983; 6 Suppl 1():S35-51. PubMed ID: 6139165
    [No Abstract]   [Full Text] [Related]  

  • 82. The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia.
    Gardos G; Cole JO; Matthews JD; Nierenberg AA; Dugan SJ
    Neuropsychopharmacology; 1992 Jun; 6(4):241-7. PubMed ID: 1352977
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lithium potentiation of neuroleptic-related extrapyramidal side effects.
    Sachdev PS
    Am J Psychiatry; 1986 Jul; 143(7):942. PubMed ID: 3087223
    [No Abstract]   [Full Text] [Related]  

  • 84. Parkinsonian symptoms in tardive dyskinesia. A prevalence study.
    Myslobodsky MS; Holden T; Sandler R
    S Afr Med J; 1986 Mar; 69(7):424-6. PubMed ID: 3961632
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neuroleptic-induced persistent "open mouth".
    Priebe S; Stahl HP; Deymann R
    Pharmacopsychiatry; 1989 May; 22(3):126-7. PubMed ID: 2568646
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Treatment of the neuroleptic malignant syndrome with bromocriptine.
    Dhib-Jalbut S; Hesselbrock R; Brott T; Silbergeld D
    JAMA; 1983 Jul 22-29; 250(4):484-5. PubMed ID: 6134848
    [No Abstract]   [Full Text] [Related]  

  • 87. Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system.
    Bartels M; Themelis J
    Arch Psychiatr Nervenkr (1970); 1983; 233(5):371-9. PubMed ID: 6139995
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Electromechanical characteristics of tardive dyskinesia.
    Wirshing WC; Cummings JL; Dencker SJ; May PR
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):10-7. PubMed ID: 7580166
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cognitive dysfunction and tardive dyskinesia.
    Struve FA; Willner AE
    Br J Psychiatry; 1983 Dec; 143():597-600. PubMed ID: 6140972
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Spastic dysphonia and denervation signs in a young man with tardive dyskinesia.
    Lieberman JA; Reife R
    Br J Psychiatry; 1989 Jan; 154():105-9. PubMed ID: 2570614
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Tardive dyskinesia complicated by hyperthyroidism.
    Munetz MR; Ginchereau EH; Toenniessen LM
    Psychosomatics; 1987 Oct; 28(10):553-5. PubMed ID: 3432519
    [No Abstract]   [Full Text] [Related]  

  • 92. The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate.
    Glazer WM; Moore DC
    J Nerv Ment Dis; 1980 Jul; 168(7):439-41. PubMed ID: 7400795
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relationship of mitten patterns to neuroleptic drug induced dyskinesias in psychiatric patients: early investigative findings.
    Struve FA; Kane JM; Wegner JT; Kantor J
    Clin Electroencephalogr; 1979 Jul; 10(3):151-63. PubMed ID: 38924
    [No Abstract]   [Full Text] [Related]  

  • 94. Lithium neurotoxicity in patients with degenerative brain disease.
    Coffey CE; Ross DR
    J Clin Psychiatry; 1985 Aug; 46(8):354. PubMed ID: 4019426
    [No Abstract]   [Full Text] [Related]  

  • 95. Drug induced dyskinesia: a critical review.
    Ananth J
    Int Pharmacopsychiatry; 1979; 14(1):21-33. PubMed ID: 39039
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tardive and withdrawal dyskinesia in autistic children: a prospective study.
    Campbell M; Adams P; Perry R; Spencer EK; Overall JE
    Psychopharmacol Bull; 1988; 24(2):251-5. PubMed ID: 3212157
    [No Abstract]   [Full Text] [Related]  

  • 97. [Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
    Horikawa H; Konagaya M; Mano Y; Takayanagi T
    Rinsho Shinkeigaku; 1985 Jun; 25(6):653-8. PubMed ID: 4053459
    [No Abstract]   [Full Text] [Related]  

  • 98. Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect.
    Zengotita HE; Holt RJ
    J Clin Psychiatry; 1986 Jan; 47(1):35-7. PubMed ID: 3941056
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Biofeedback treatment of tardive dyskinesia: two case reports.
    Albanese H; Gaardner K
    Am J Psychiatry; 1977 Oct; 134(10):1149-50. PubMed ID: 900274
    [No Abstract]   [Full Text] [Related]  

  • 100. Tardive dyskinesia status: stability or change.
    Richardson MA; Casey DE
    Psychopharmacol Bull; 1988; 24(3):471-5. PubMed ID: 3153511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.